Therapeutische Impfstoffe

European patent · EP2737906 · In force

Register entry

Publication number
EP2737906
Application number
EP14156495
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 22, 2009
Published
Jun 4, 2014
Granted
Feb 28, 2018
Protection ends at the latest
Jan 21, 2029
Next annual fee due
Jan 31, 2027
IPC classes
A61K 39/00 (2006.01)
A61K 39/39 (2006.01)
C07K 14/47 (2006.01)
C07K 7/64 (2006.01)
C07K 7/08 (2006.01)
Priority
GB 0801424 25.01.2008
GB 0802405 08.02.2008
GR 20080100151 29.02.2008
Divided from
EP09703874
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Feb 28, 2018

    Granted

    Published in Swissreg on 28.02.2018

Parties

Holder

Vianex S.A.

Tatoiou Street 18th Kilometre Athens-Lamia National Road, 146 71 Nea Erythrea, GR

Inventor

Matsoukas, John

Patras, GR

Tselios, Theodore

Mesologgi, GR

Apostolopoulos, Vasso

Victoria 3021, New South Wales, AU

Tseveleki, Vivian

Drosia, GR

Katsara, Maria

Kalamata, GR

Probert, Lesley

Athens, GR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.